Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 2000 Jul;83(1):F24–F27. doi: 10.1136/fn.83.1.F24

Controlled trial of immune response of preterm infants to recombinant hepatitis B and inactivated poliovirus vaccines administered simultaneously shortly after birth

N Linder, R Handsher, B German, L Sirota, M Bachman, S Zinger, E Mendelson, A Barzilai
PMCID: PMC1721105  PMID: 10873167

Abstract

AIM—The study was conducted to evaluate the immunogenicity of an early, extra dose of enhanced inactivated poliovirus vaccine (IPV) administered simultaneously with recombinant hepatitis B vaccine (HBV) to preterm infants shortly after birth.
METHODS—Three groups were studied. Fifty preterm infants received IPV intramuscularly within 24 hours of birth, in addition to routine recommended childhood immunisations. Fifty two preterm infants and 35 full term infants received routine immunisations only (routine vaccination timing: HBV at birth, 1 and 6 months of age; IPV at 2 and 4 months; oral polio vaccine (OPV) at 4 and 6 months; diphtheria-tetanus-pertussis (DTP) at 2, 4, and 6 months; and Haemophilus influenzae B vaccine at 2 and 4 months). Blood samples were taken at birth, 3 and 7months of age from all infants, and at 1 month of age from preterm infants only.
RESULTS—At birth, a lower percentage of both study and control preterm infants had antipoliovirus type 3 titres ⩾ 1:8 than full term infants. At 1 and 3 months of age significantly more early IPV infants had antipoliovirus type 3 titres ⩾ 1:8 than routinely vaccinated preterm infants (p < 0.05). At 7 months of age there were no significant differences in percentage of antipoliovirus titres ⩾ 1:8 or geometric mean times (GMTs) between the early IPV group and the routinely vaccinated preterm group. At 3 and 7 months of age, the percentage of positive antihepatitis B titres (⩾ 1:10) and the GMT of the early IPV preterm group did not differ significantly from those of preterm controls. There was no significant difference in percentage of positive antihepatitis B titres between the early IPV group and full term controls at any time. GMTs for hepatitis B antibodies were significantly lower in the early IPV preterm group than in full term controls at 3 and 7 months of age.
CONCLUSIONS—Administration of an additional dose of IPV simultaneously with routine HBV to preterm infants shortly after birth provides early protection from poliovirus and hepatitis B infection, and does not interfere with poliovirus antibody production at the age of 7months.



Full Text

The Full Text of this article is available as a PDF (124.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adenyi-Jones S. C., Faden H., Ferdon M. B., Kwong M. S., Ogra P. L. Systemic and local immune responses to enhanced-potency inactivated poliovirus vaccine in premature and term infants. J Pediatr. 1992 May;120(5):686–689. doi: 10.1016/s0022-3476(05)80228-8. [DOI] [PubMed] [Google Scholar]
  2. Ambrosch F., André F. E., Delem A., D'Hondt E., Jonas S., Kunz C., Safary A., Wiedermann G. Simultaneous vaccination against hepatitis A and B: results of a controlled study. Vaccine. 1992;10 (Suppl 1):S142–S145. doi: 10.1016/0264-410x(92)90570-a. [DOI] [PubMed] [Google Scholar]
  3. Barone P., Mauro L., Leonardi S., Ienna M., Giammanco Bilancia G., Falcidia E., Musumeci S. Simultaneous administration of HB recombinant vaccine with diphtheria and tetanus toxoid and oral polio vaccine: a pilot study. Acta Paediatr Jpn. 1991 Aug;33(4):455–458. doi: 10.1111/j.1442-200x.1991.tb02571.x. [DOI] [PubMed] [Google Scholar]
  4. Chawareewong S., Jirapongsa A., Lokaphadhana K. Immune response to hepatitis B vaccine in premature neonates. Southeast Asian J Trop Med Public Health. 1991 Mar;22(1):39–40. [PubMed] [Google Scholar]
  5. Coursaget P., Relyveld E., Brizard A., Frenkiel M. P., Fritzell B., Teulières L., Bourdil C., Yvonnet B., Jeannée E., Guindo S. Simultaneous injection of hepatitis B vaccine with BCG and killed poliovirus vaccine. Vaccine. 1992;10(5):319–321. doi: 10.1016/0264-410x(92)90370-y. [DOI] [PubMed] [Google Scholar]
  6. Dong D. X., Hu X. M., Liu W. J., Li J. S., Jin Y. C., Tan S. G., Chen T. Q., Fu J. Z., Niu B. Y., Yu H. M. Immunization of neonates with trivalent oral poliomyelitis vaccine (Sabin). Bull World Health Organ. 1986;64(6):853–860. [PMC free article] [PubMed] [Google Scholar]
  7. Evans H. E., Akpata S. O., Glass L. Serum immunoglobulin levels in premature and full-term infants. Am J Clin Pathol. 1971 Sep;56(3):416–418. doi: 10.1093/ajcp/56.3.416. [DOI] [PubMed] [Google Scholar]
  8. Flehmig B., Heinricy U., Pfisterer M. Simultaneous vaccination for hepatitis A and B. J Infect Dis. 1990 May;161(5):865–868. doi: 10.1093/infdis/161.5.865. [DOI] [PubMed] [Google Scholar]
  9. Giammanco G., Li Volti S., Mauro L., Bilancia G. G., Salemi I., Barone P., Musumeci S. Immune response to simultaneous administration of a recombinant DNA hepatitis B vaccine and multiple compulsory vaccines in infancy. Vaccine. 1991 Oct;9(10):747–750. doi: 10.1016/0264-410x(91)90291-d. [DOI] [PubMed] [Google Scholar]
  10. Halsey N., Galazka A. The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age. Bull World Health Organ. 1985;63(6):1151–1169. [PMC free article] [PubMed] [Google Scholar]
  11. Kim S. C., Chung E. K., Hodinka R. L., DeMaio J., West D. J., Jawad A. F., Watson B. Immunogenicity of hepatitis B vaccine in preterm infants. Pediatrics. 1997 Apr;99(4):534–536. doi: 10.1542/peds.99.4.534. [DOI] [PubMed] [Google Scholar]
  12. Lau Y. L., Tam A. Y., Ng K. W., Tsoi N. S., Lam B., Lam P., Yeung C. Y. Response of preterm infants to hepatitis B vaccine. J Pediatr. 1992 Dec;121(6):962–965. doi: 10.1016/s0022-3476(05)80352-x. [DOI] [PubMed] [Google Scholar]
  13. Linder N., Taushtein I., Handsher R., Ohel G., Reichman B., Barzilai A., Kuint J., Davidovitch N., Mendelson E., Dagan R. Placental transfer of maternal poliovirus antibodies in full-term and pre-term infants. Vaccine. 1998 Jan-Feb;16(2-3):236–239. doi: 10.1016/s0264-410x(97)00180-1. [DOI] [PubMed] [Google Scholar]
  14. Linder N., Yaron M., Handsher R., Kuint J., Birenbaum E., Mazkereth R., Lubin D., Mendelson E., Safrir O., Reichman B. Early immunization with inactivated poliovirus vaccine in premature infants. J Pediatr. 1995 Jul;127(1):128–130. doi: 10.1016/s0022-3476(95)70272-5. [DOI] [PubMed] [Google Scholar]
  15. PAGANO J. S., PLOTKIN S. A., CORNELY D., LEUTERER W., KOPROWSKI H. The response of premature infants to infection with attenuated poliovirus. Pediatrics. 1962 May;29:794–807. [PubMed] [Google Scholar]
  16. Slater P. E., Orenstein W. A., Morag A., Avni A., Handsher R., Green M. S., Costin C., Yarrow A., Rishpon S., Havkin O. Poliomyelitis outbreak in Israel in 1988: a report with two commentaries. Lancet. 1990 May 19;335(8699):1192–1198. doi: 10.1016/0140-6736(90)92705-m. [DOI] [PubMed] [Google Scholar]
  17. Smolen P., Bland R., Heiligenstein E., Lawless M. R., Dillard R., Abramson J. Antibody response to oral polio vaccine in premature infants. J Pediatr. 1983 Dec;103(6):917–919. doi: 10.1016/s0022-3476(83)80714-8. [DOI] [PubMed] [Google Scholar]
  18. Swartz T. A., Handsher R., Stoeckel P., Drucker J., Caudrelier P., Van Wezel A. L., Cohen H., Salk D., Salk J. Immunologic memory induced at birth by immunization with inactivated polio vaccine in a reduced schedule. Eur J Epidemiol. 1989 Jun;5(2):143–145. doi: 10.1007/BF00156819. [DOI] [PubMed] [Google Scholar]
  19. Weckx L. Y., Schmidt B. J., Herrmann A. A., Miyasaki C. H., Novo N. F. Early immunization of neonates with trivalent oral poliovirus vaccine. Bull World Health Organ. 1992;70(1):85–91. [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES